IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 63 full-time employees. The company went IPO on 2018-06-01. The firm has sold all of its assets. The company is not engaged in any business operations.
Follow-Up Questions
IMV Inc (IMVIF)의 PER은 얼마입니까?
IMV Inc의 PER은 0입니다
IMV Inc의 CEO는 누구입니까?
Mr. Andrew Hall은 2020부터 회사에 합류한 IMV Inc의 Chief Executive Officer입니다.
IMVIF 주식의 가격 성능은 어떻습니까?
IMVIF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
IMV Inc의 주요 사업 주제나 업종은 무엇입니까?
IMV Inc은 Biotechnology 업종에 속하며, 해당 부문은 Health Care입니다
